Opening Asia for Russia

More than 19,000 doctors received Sputnik V vaccine in Kazakhstan

22.02.2021 37 просмотров

In Kazakhstan, more than 19,000 healthcare workers have been vaccinated with the Sputnik V vaccine.


Over 19,000 medical workers in Kazakhstan have been vaccinated against coronavirus infection with the Russian Sputnik V vaccine. This was reported by the press service of the Ministry of Health on Monday.

“As of February 21, 19,764 medical workers in Kazakhstan received the Sputnik V vaccine. No adverse reactions were identified,” the report says.

According to the agency, vaccination in the country is proceeding according to the planned schedule. The vaccine will be given to health workers, teachers, law enforcement officers and students in the first place. “The first batch of the vaccine arrived in Kazakhstan from the Russian Federation on January 31, 2021. After carrying out the necessary procedures, the cargo was distributed to large hubs of the single distributor of medicines "SK-Pharmacy", located in the cities of Nur-Sultan, Alma-Ata, Shymkent and Aktobe. Then the vaccine was delivered to all regions of the republic,” the ministry explained.

Currently, the production of the Sputnik V vaccine has been established on the basis of the Karaganda Pharmaceutical Complex (KPC). In February, 90 thousand doses of the vaccine were produced here, in March they plan to produce 150 thousand doses, and from April to June to produce 600 thousand doses monthly.

On February 15, the Ministry of Health of Kazakhstan issued a registration certificate for the Sputnik V vaccine ”, produced on the basis of KFK. The first batch of the drug passes quality control at the Gamaleya Center. Its shipment to the sole distributor of medicines in Kazakhstan - the company "SK-Pharmacy" is scheduled for the end of February. rossiyskim-preparatom-sputnik-v-nachinaetsya-v-kazakhstane/">On February 1, vaccination of the population against coronavirus infection using the Sputnik V vaccine, which was produced in Russia, began in Kazakhstan. By the end of this month, the drug is expected to be used "Sputnik V", produced on the basis of the Karaganda pharmaceutical complex. Starting from the second quarter of this year, it is planned to involve the Kazakh-made vaccine QazCovid-in (“Kazkovid-in”), which is currently undergoing the third phase of clinical trials, in the process of vaccinating the population.

Новости партнёров